325 related articles for article (PubMed ID: 17954026)
21. Pigmentary sequelae of AIDS-related cutaneous Kaposi sarcoma: successful treatment by Q-switched 755-nm alexandrite and 532-nm Nd:YAG lasers.
Hughes R; Lacour JP; Passeron T
Arch Dermatol; 2011 Jul; 147(7):779-81. PubMed ID: 21768476
[No Abstract] [Full Text] [Related]
22. Bigger Foot: Kaposi's Sarcoma.
Rapaka RR; Fischer M; Finucane TE; Mwakingwe A
Am J Med; 2015 Sep; 128(9):959-62. PubMed ID: 26055548
[No Abstract] [Full Text] [Related]
23. Efavirenz helps get rid of Kaposi's sarcoma (KS).
TreatmentUpdate; 2002 Feb; 14(2):2-3. PubMed ID: 12691038
[No Abstract] [Full Text] [Related]
24. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
[TBL] [Abstract][Full Text] [Related]
25. NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.
Goodier MR; Mela CM; Steel A; Gazzard B; Bower M; Gotch F
J Virol; 2007 Jan; 81(1):430-3. PubMed ID: 17035308
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma and protection from AIDS dementia complex.
Dore GJ; Grulich A; Law MG; Brew BJ; Kaldor JM
AIDS; 1998 Dec; 12(17):2354-5. PubMed ID: 9863882
[No Abstract] [Full Text] [Related]
28. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
[TBL] [Abstract][Full Text] [Related]
29. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.
Deyton LR; Walker RE; Kovacs JA; Herpin B; Parker M; Masur H; Fauci AS; Lane HC
N Engl J Med; 1989 Nov; 321(18):1246-9. PubMed ID: 2638573
[No Abstract] [Full Text] [Related]
30. AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART): an African perspective.
Sissolak G; Abayomi EA; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):63-70. PubMed ID: 17931978
[TBL] [Abstract][Full Text] [Related]
31. Fatal Disseminated Kaposi's Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection.
Fardin RB; Leite LAC; Bezerra LMDS; Alves PMP; Dos Santos LL; Salvá MA; Rezende Filho ALSM; Lima GS; Matos JA; Ferreira SMS; Costa DLJF
Am J Case Rep; 2018 Jul; 19():868-874. PubMed ID: 30042376
[TBL] [Abstract][Full Text] [Related]
32. Effect of anti retroviral therapy (ART) on CD4 T lymphocyte count and the spectrum of opportunistic infections in HIV/AIDS in Manipur.
Chitra Y; Urgen S; Dayananda I; Brajachand SN
J Commun Dis; 2009 Mar; 41(1):19-24. PubMed ID: 19886171
[TBL] [Abstract][Full Text] [Related]
33. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.
Murphy M; Armstrong D; Sepkowitz KA; Ahkami RN; Myskowski PL
AIDS; 1997 Feb; 11(2):261-2. PubMed ID: 9030382
[No Abstract] [Full Text] [Related]
34. Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa.
Mosam A; Cassol E; Page T; Bodasing U; Cassol S; Dawood H; Friedland GH; Scadden DT; Aboobaker J; Jordaan JP; Lalloo UG; Esterhuizen TM; Coovadia HM
AIDS; 2005 Mar; 19(4):441-3. PubMed ID: 15750399
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results.
Afrasiabi R; Mitsuyasu RT; Nishanian P; Schwartz K; Fahey JL
Am J Med; 1986 Dec; 81(6):969-73. PubMed ID: 2948385
[TBL] [Abstract][Full Text] [Related]
36. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
37. [Kaposi's sarcoma of the bile ducts with cutaneous involvement in a patient with AIDS].
Segarra P; Abril V; Gil M; Ortega E; Ballester JE; Traves V
Rev Esp Enferm Dig; 1996 Sep; 88(9):637-9. PubMed ID: 8962781
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of highly active antiretroviral therapy for childhood acquired immunodeficiency syndrome].
Hao JL; Wang BJ; Baptiste J
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):874-6. PubMed ID: 21083982
[TBL] [Abstract][Full Text] [Related]
39. What's new: acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma.
Lucia HL
Tex Med; 1983 Jun; 79(6):39-40. PubMed ID: 6308845
[No Abstract] [Full Text] [Related]
40. Spontaneously healing Kaposi's sarcoma in AIDS.
Janier M; Vignon MD; Cottentot F
N Engl J Med; 1985 Jun; 312(25):1638-9. PubMed ID: 4000204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
